Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteoglycans01:05

Proteoglycans

5.1K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vepdegestrant for ESR1-mutated breast cancer.

Trends in pharmacological sciences·2026
Same author

Phytochemicals remodel antitumor immunity via the "microbiota-metabolite-receptor" axis: focus on colorectal cancer and immunotherapy.

Medical oncology (Northwood, London, England)·2026
Same author

Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension.

bioRxiv : the preprint server for biology·2026
Same author

Glycolysis-driven cancer-associated fibroblasts shape T-Cell exclusion via the CXCL16-CXCR6 Axis: a metabolic-chemokine mechanism in tumor immunity.

Journal of translational medicine·2026
Same author

<i>Valeriana</i> species and insomnia: multi-organ mechanisms and translational perspectives.

Pharmaceutical biology·2026
Same author

Metabolomics of Right Ventricular Function in Pulmonary Hypertension.

Circulation research·2026

Related Experiment Video

Updated: Mar 16, 2026

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
07:56

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

29.4K

Association Between Progranulin and Gaucher Disease.

Jinlong Jian1, Shuai Zhao1, Qing-Yun Tian1

  • 1Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY 10003, United States.

Ebiomedicine
|August 13, 2016
PubMed
Summary

Progranulin (PGRN) deficiency is linked to Gaucher disease (GD), a genetic disorder. PGRN is essential for lysosomal enzyme localization, and PGRN replacement therapy shows promise for treating GD.

Keywords:
Gaucher diseaseLysosomal storage diseasesProgranulinβ-Glucocerebrosidase

More Related Videos

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
07:58

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis

Published on: February 25, 2014

29.9K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.5K

Related Experiment Videos

Last Updated: Mar 16, 2026

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
07:56

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

29.4K
Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
07:58

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis

Published on: February 25, 2014

29.9K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.5K

Area of Science:

  • Genetics
  • Biochemistry
  • Lysosomal Storage Disorders

Background:

  • Gaucher disease (GD) is a genetic disorder caused by GBA1 gene mutations, leading to reduced beta-glucocerebrosidase (GCase) activity.
  • This study identifies the progranulin (PGRN) gene (GRN) as a novel genetic factor associated with GD.

Purpose of the Study:

  • To investigate the association between progranulin (PGRN) and Gaucher disease (GD).
  • To determine the role of PGRN in GCase lysosomal localization and explore PGRN as a therapeutic target for GD.

Main Methods:

  • Serum PGRN levels were measured in GD patients and healthy controls.
  • Whole GRN gene sequencing and SNP genotyping were performed in GD patients and controls.
  • PGRN-deficient mice were used to characterize GD development and test recombinant PGRN (rPGRN) therapy.

Main Results:

  • GD patients exhibited significantly lower serum PGRN levels compared to healthy controls.
  • Four GRN gene SNPs and three point mutations were identified in GD patients, with SNPs showing higher frequency in GD.
  • PGRN deficiency in mice led to GD-like phenotypes and impaired GCase lysosomal localization, while rPGRN demonstrated therapeutic effects.

Conclusions:

  • PGRN is associated with Gaucher disease and is crucial for the lysosomal localization of GCase.
  • These findings offer new insights into GD pathogenesis and suggest PGRN's potential in GD diagnosis and therapy.